$RGNT
Regentis Biomaterials Ltd.
NYSE · Healthcare · Orthopedic, Prosthetic & Surgical Appliances & Supplies · Or Akiva
RGNT chart
What traders are saying about $RGNT
Latest postsRegentis Biomaterials Ltd. news
- Regentis Biomaterials Ltd (RGNT) Signs Four-Year Israel Distribution Deal for GelrinC
TradingView ·
- Regentis Biomaterials (NYSE American: RGNT) Signs Four-Year Exclusive Distribution Agreement for GelrinC
Benzinga ·
- Regentis Biomaterials Signs Exclusive Distribution Agreement With Ami Technologies To Commercialize Gelrinc In Israel
TradingView ·
- Regentis Biomaterials Signs Exclusive Israel Distribution Deal for GelrinC
TipRanks ·
- A four-year exclusive Israel deal has Regentis (RGNT) expecting revenue contributions.
Stock Titan ·
- Regentis Signs Exclusive Distribution Agreement with AMI Technologies to Commercialize GelrinC(R) in Israel
Yahoo Finance ·
- Regentis Biomaterials Ltd. (RGNT) Signs Israel Deal With 2027 Revenue Expected
TradingView ·
- Regentis Biomaterials Share News - Latest Updates, Live News & More
scanx.trade ·
- Regentis Biomaterials Reports Strong Surgeon Interest in GelrinC(R) at 8th ICRS Summit in Portugal
Yahoo Finance ·
- Regentis Biomaterials to Present at the 2026 ThinkEquity Conference on October 15 in New York City
Yahoo Finance ·
- IBN Announces Latest Episode of The BioMedWire Podcast Featuring Dr. Ehud Geller, CEO of Regentis Biomaterials Ltd.
Yahoo Finance ·
- Regentis Biomaterials (RGNT) Advances GelrinC as a Potential New Approach to Knee Cartilage Repair
Yahoo Finance ·
Regentis Biomaterials Ltd. key financials
| USD | 2025 | 2024 | 2023 |
|---|---|---|---|
| Net income | -$13.6M | $4.8M | -$4.1M |
| Diluted EPS | $-24.16 | $1.72 | $-24.09 |
| Total assets (year end) | $7.6M | $482,000 | – |
| Cash and equivalents (year end) | $7.4M | – | – |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
- 6-K6-K
- 6-KREPORT OF FOREIGN PRIVATE ISSUER
- 6-KREPORT OF FOREIGN PRIVATE ISSUER
- 6-KREPORT OF FOREIGN PRIVATE ISSUER
- 6-KREPORT OF FOREIGN PRIVATE ISSUER
- 6-KREPORT OF FOREIGN PRIVATE ISSUER
- 6-KREPORT OF FOREIGN PRIVATE ISSUER
- 6-KREPORT OF FOREIGN PRIVATE ISSUER
- 6-KREPORT OF FOREIGN PRIVATE ISSUER
- 6-KREPORT OF FOREIGN PRIVATE ISSUER
- 6-KREPORT OF FOREIGN PRIVATE ISSUER
- 20-FANNUAL REPORT
About Regentis Biomaterials Ltd.
- Ticker
- RGNT (NYSE)
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- Headquarters
- Or Akiva
- Incorporated in
- Israel
- Fiscal year end
- December 31
- SEC CIK
- 1912966
Frequently asked questions
What exchange is Regentis Biomaterials Ltd. listed on?
Regentis Biomaterials Ltd. trades on the NYSE under the ticker symbol RGNT.
What industry is Regentis Biomaterials Ltd. in?
Regentis Biomaterials Ltd. is classified by the SEC under "Orthopedic, Prosthetic & Surgical Appliances & Supplies", part of the Healthcare sector on StockTweeting.
Where is Regentis Biomaterials Ltd. headquartered?
Regentis Biomaterials Ltd.'s business address on file with the SEC is in Or Akiva.
When does Regentis Biomaterials Ltd.'s fiscal year end?
Regentis Biomaterials Ltd.'s fiscal year ends on December 31.